EDITORS’ CHOICE

HEALTH

Nikon

COVID-19 forced us to reimagine pharma supply chains – and that’s a good thing.

BIO’s Chief Policy Officer John Murphy joined a panel hosted by The Hill to discuss how the pandemic affected drug supply chains and the opportunity to improve them going forward.

AGRICULTURE

PSC

CLIMATE CHANGE

FEDERAL POLICY

STATE POLICY

INTERNATIONAL

BIO’s VIEW

 

GET DAILY BIOTECH NEWS IN YOUR INBOX

Scroll to Top
SUBSCRIBE TO THE FREE GOOD DAY BIO NEWSLETTER